1125 related articles for article (PubMed ID: 11002725)
21. Combined therapy of captopril and spironolactone for refractory congestive heart failure.
Han YL; Tong M; Jing QM; Hu XL; Liu JQ
Chin Med J (Engl); 1994 Sep; 107(9):688-92. PubMed ID: 7805462
[TBL] [Abstract][Full Text] [Related]
22. Acid-base and electrolyte disorders in patients with diabetes mellitus.
Sotirakopoulos N; Kalogiannidou I; Tersi M; Armentzioiou K; Sivridis D; Mavromatidis K
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):58-62. PubMed ID: 22237220
[TBL] [Abstract][Full Text] [Related]
23. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
Mahmood SA; Hussein GM; Hamza EA
Saudi Med J; 2004 Aug; 25(8):1060-5. PubMed ID: 15322598
[TBL] [Abstract][Full Text] [Related]
24. [Malignant arrhythmias caused by hyperkalemia: a new area of drug-induced electrolyte abnormalities].
Tomcsányi J; Somlói M; Arabadzisz H; Horváth L
Orv Hetil; 2002 Mar; 143(13):663-6. PubMed ID: 11975043
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic approach in patients with dysnatraemias.
Liamis G; Kalogirou M; Saugos V; Elisaf M
Nephrol Dial Transplant; 2006 Jun; 21(6):1564-9. PubMed ID: 16449285
[TBL] [Abstract][Full Text] [Related]
26. Hyponatraemia: etiology, management and outcome.
Yawar A; Jabbar A; Haque NU; Zuberi LM; Islam N; Akhtar J
J Coll Physicians Surg Pak; 2008 Aug; 18(8):467-71. PubMed ID: 18798581
[TBL] [Abstract][Full Text] [Related]
27. Severe hyperkalemia during piroxicam therapy.
Miller KP; Lazar EJ; Fotino S
Arch Intern Med; 1984 Dec; 144(12):2414-5. PubMed ID: 6508449
[TBL] [Abstract][Full Text] [Related]
28. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
29. The metabolic and respiratory alterations of heat stroke.
Sprung CL; Portocarrero CJ; Fernaine AV; Weinberg PF
Arch Intern Med; 1980 May; 140(5):665-9. PubMed ID: 7396591
[TBL] [Abstract][Full Text] [Related]
30. Exposure of the elderly to potential nephrotoxic drug combinations in Belgium.
Smets HL; De Haes JF; De Swaef A; Jorens PG; Verpooten GA
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):1014-9. PubMed ID: 18763247
[TBL] [Abstract][Full Text] [Related]
31. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
32. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
[TBL] [Abstract][Full Text] [Related]
33. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
[TBL] [Abstract][Full Text] [Related]
34. [Influence of insulinfree rehydration on diabetic derangements (author's transl)].
Kleinberger G
Wien Klin Wochenschr; 1980 Sep; 92(17):616-29. PubMed ID: 7006220
[TBL] [Abstract][Full Text] [Related]
35. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
Goldsmith SR
Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
[TBL] [Abstract][Full Text] [Related]
36. Intensity and focus of heart failure disease management after hospital discharge.
Shah MR; Flavell CM; Weintraub JR; Young MA; Hasselblad V; Fang JC; Nohria A; Lewis EF; Givertz MM; Mudge G; Stevenson LW
Am Heart J; 2005 Apr; 149(4):715-21. PubMed ID: 15990758
[TBL] [Abstract][Full Text] [Related]
37. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
Weidmann P
Schweiz Med Wochenschr; 1982 Dec; 112(49):1764-74. PubMed ID: 6758113
[TBL] [Abstract][Full Text] [Related]
38. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
39. In right or biventricular chronic heart failure addition of thiazides to loop diuretics to achieve a sequential blockade of the nephron is associated with increased risk of dilutional hyponatremia: results of a case-control study.
De Vecchis R; Ariano C; Esposito C; Giasi A; Cioppa C; Cantatrione S
Minerva Cardioangiol; 2012 Oct; 60(5):517-29. PubMed ID: 23018431
[TBL] [Abstract][Full Text] [Related]
40. Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients.
Henger A; Tutt P; Riesen WF; Hulter HN; Krapf R
J Lab Clin Med; 2000 Nov; 136(5):379-89. PubMed ID: 11079465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
